Search results
Council Post: How Multi-Omics Is Empowering The Discovery Of Cancer Biomarkers
Forbes· 11 hours agoDemaris Mills is president at Integrated DNA Technologies, a global genomics solutions provider....
Surprising origins for a rare cancer: Study finds overexpression of PKA protein causes fibrolamellar...
Medical Xpress· 1 hour agoSimon, whose own then-teenage daughter, Elana, had not only been diagnosed with liver disease a few...
Rutherrin(R) Increases Efficacy of Immunotherapy Preclinically
The Joplin Globe· 3 hours agoImmunotherapy, the latest technology in the war on cancer, can come in various forms; including: checkpoint inhibitors, ...
Lilly and subsidiary Point Biopharma accused of patent infringement of cancer drugs - Indianapolis...
Indianapolis Business Journal· 1 day agoEli Lilly and Co. and a biopharma company it bought last year are accused of infringing on the...
Radioactive drugs strike cancer with precision
Knowable Magazine via Yahoo News· 6 days agoThe Endocyte acquisition brought a PSMA-targeted agent that would prove to be a real game-changer — both for patients with certain difficult-to-treat...
Gateway - Quartz
Quartz· 19 minutes agoA U.S. Food and Drug Administration (FDA) advisory committee is met Thursday to review a new blood test by the biotech company Guardant Health that checks for colorectal & ...
FDA approves MSD’s KEYTRUDA for advanced endometrial cancer
Pharmaceutical Technology via Yahoo Finance· 8 hours agoThe US Food and Drug Administration (FDA) has approved MSD’s anti-PD-1 therapy KEYTRUDA for use with...
AstraZeneca Imfinzi plus chemotherapy gets US nod for certain type of endometrial cancer
WHTC 1450 Holland· 1 day ago(Reuters) - AstraZeneca said its blockbuster cancer drug Imfinzi combined with chemotherapy has been...
Zentalis Pharmaceuticals Shares Slide on Partial Clinical Holds on Cancer Drug Studies
Market Watch· 5 hours agoPublished: June 18, 2024 at 7:44 a.m. ETShareResizeBy Adriano MarcheseAbout Dow Jones NewswiresDow Jones Newswires is a market-moving financial and business news source, used by wealth managers ...
Gateway - Quartz
Quartz· 8 hours agoPharma giant Merck said on Wednesday that it is acquiring the privately-held eye drug developer Eyebiotech (EyeBio) as the company tries to diversify beyond its best-selling ...
